Ogeda currently has one ongoing partnerships

Over the years, Ogeda has developed a strong R&D partnering track record with pharmaceutical companies, including Boehringer Ingelheim, Cephalon, Grunenthal, HGS, Janssen Pharmaceuticals, Merck Sharp & Dohme and Pfizer



In 2009 Ogeda started a research collaboration with Novartis, through it's Euroscreen Fast business unit, for the identification of natural ligands of orphan receptors. Novartis is responsible for subsequent drug discovery activities related to these receptors. While the active part of the collaboration is finalized, Ogeda may potentially receive further payments in the future.